Clinical Trial Update: Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effects of nicorandil on reducing infarct size in patients with ST-segment elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Myocardial Infarction | Phase 3 | Status: UNKNOWN